Efficacy of TECAR Therapy on Patient With Mechanical Neck Pain
Influence of TECAR Therapy on Cervical Mobility and Functional Disability in Patients With Mechanical Neck Pain: Randomized Control Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:
- Does TECAR therapy reduce pain intensity in patients with mechanical neck pain?
- Does TECAR therapy improve cervical range of motion (CROM)?
- Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain. Participants will:
- Attend scheduled treatment sessions during the study period
- Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone
- Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedStudy Start
First participant enrolled
June 7, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
Study Completion
Last participant's last visit for all outcomes
October 10, 2026
May 22, 2026
May 1, 2026
3 months
May 13, 2026
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity
Pain intensity was measured using the Visual Analog Scale (VAS) to assess changes in neck pain intensity throughout the study period. The VAS is a self-reported pain assessment tool consisting of a 10-cm horizontal line, with scores ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity and therefore a worse outcome.
Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Secondary Outcomes (2)
Cervical Range of Motion (CROM)
Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Functional Disability
Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)
Study Arms (2)
TECAR Therapy Group for Mechanical Neck Pain
EXPERIMENTALParticipants will receive TECAR therapy combined with a conventional physical therapy program for mechanical neck pain.
Conventional Physical Therapy Group for Mechanical Neck Pain
ACTIVE COMPARATORParticipants will receive a conventional physical therapy program only.
Interventions
Participants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group.
Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.
Eligibility Criteria
You may qualify if:
- Presence of neck pain for at least 3 months
- Limited cervical range of motion associated with neck pain
- Ability to understand and follow study instructions Willingness to participate and sign the informed consent form
You may not qualify if:
- History of cervical spine surgery or fracture
- Cervical radiculopathy or other neurological disorders
- Presence of inflammatory, rheumatic, or systemic diseases affecting the cervical spine
- Severe cervical disc prolapse or spinal instability Current participation in another treatment program for neck pain Pregnancy Presence of pacemakers, metal implants, or contraindications to TECAR therapy Skin disorders or open wounds in the treatment area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Batterjee Medical Collegelead
- Saudi German Hospitalcollaborator
Study Sites (1)
Saudi German Hospital
Jeddah, Al Zahraa, 23623, Saudi Arabia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 13, 2026
First Posted
May 19, 2026
Study Start (Estimated)
June 7, 2026
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
October 10, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share